**Author Information** An event is serious (based on the ICH definition) when the patient outcome is:\* death\* life-threatening\* hospitalisation\* disability\* congenital anomaly\* other medically important event

In a study, an elderly woman \[*age at the time of reaction onset not stated*\] developed drug-induced liver injury leading to acute liver failure and hepatic encephalopathy following treatment with rifampicin for Methicillin-resistant Staphylococcus aureus bacteraemia from presumed prosthetic valve endocarditis.

The woman aged 89 years presented with fever, dyspnea and acute liver disease. Following her presentation, she was diagnosed with SARS-CoV-2 infection by real-time polymerase chain reaction (PCR) from a nasopharyngeal swab specimen. The routine peripheral blood smears showed blue-green inclusions in monocytes. She had previously been hospitalized for methicillin-resistant *Staphylococcus aureus* bacteraemia due to presumed prosthetic valve endocarditis. At that time, she had received treatment with rifampicin \[rifampin; *dosage and route not stated*\] and vancomycin. However, she was readmitted for acute liver failure and hepatic encephalopathy from presumed drug-induced liver injury, secondary to rifampicin. At the time of current presentation, she also exhibited end stage renal disease secondary to diabetes mellitus. Subsequently, she developed acute kidney injury, for which, she received renal replacement therapy. Further she required intubation for acute hypoxic respiratory failure. She also developed leukocytosis and exhibited markedly elevated D-dimer. Subsequently, after 3 days from blue-green inclusions inclusions in monocytes, she died \[*exact cause of death not stated*\].
